US Stock MarketDetailed Quotes

VIRI Virios Therapeutics

Watchlist
  • 0.215
  • +0.008+3.86%
Close May 31 16:00 ET
  • 0.218
  • +0.003+1.44%
Post 18:29 ET
5.97MMarket Cap-797P/E (TTM)

Virios Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-15.62%1.31M
-55.77%5.45M
-45.54%1.14M
-50.84%1.27M
-59.77%1.48M
-60.69%1.56M
-21.26%12.32M
-50.10%2.09M
-36.95%2.59M
-14.29%3.67M
Selling and administrative expenses
-8.42%970.38K
-12.41%3.72M
2.67%839.81K
-7.20%900.09K
-27.36%919.37K
-11.12%1.06M
-12.37%4.25M
-35.55%818K
-15.68%969.95K
17.70%1.27M
-General and administrative expense
-8.42%970.38K
-12.41%3.72M
2.67%839.81K
-7.20%900.09K
-27.36%919.37K
-11.12%1.06M
-12.37%4.25M
-35.55%818K
-15.68%969.95K
17.70%1.27M
Research and development costs
-30.94%343.72K
-78.59%1.73M
-76.54%298.32K
-76.94%374.2K
-76.82%557.84K
-82.03%497.71K
-25.25%8.07M
-56.42%1.27M
-45.21%1.62M
-25.01%2.41M
Operating profit
15.62%-1.31M
55.77%-5.45M
45.54%-1.14M
50.84%-1.27M
59.77%-1.48M
60.69%-1.56M
21.26%-12.32M
50.10%-2.09M
36.95%-2.59M
14.29%-3.67M
Net non-operating interest income expense
-43.68%22.77K
123.64%150.9K
-22.60%34.95K
136.16%39.22K
655.89%36.31K
40.42K
1,089.62%67.48K
3,464.33%45.16K
1,000.40%16.61K
221.34%4.8K
Non-operating interest income
-43.68%22.77K
123.64%150.9K
-22.60%34.95K
136.16%39.22K
655.89%36.31K
--40.42K
--67.48K
--45.16K
1,000.40%16.61K
221.34%4.8K
Other net income (expense)
Income before tax
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
37.33%-2.58M
14.38%-3.67M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
37.33%-2.58M
14.38%-3.67M
Net income continuous Operations
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
37.33%-2.58M
14.38%-3.67M
Minority interest income
Net income attributable to the parent company
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
37.33%-2.58M
14.38%-3.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
37.33%-2.58M
14.38%-3.67M
Basic earnings per share
12.50%-0.07
74.77%-0.28
45.45%-0.06
78.57%-0.06
81.82%-0.08
83.33%-0.08
42.19%-1.11
79.63%-0.11
42.86%-0.28
13.73%-0.44
Diluted earnings per share
12.50%-0.07
74.77%-0.28
45.45%-0.06
78.57%-0.06
81.82%-0.08
83.33%-0.08
42.19%-1.11
79.63%-0.11
42.86%-0.28
13.73%-0.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -15.62%1.31M-55.77%5.45M-45.54%1.14M-50.84%1.27M-59.77%1.48M-60.69%1.56M-21.26%12.32M-50.10%2.09M-36.95%2.59M-14.29%3.67M
Selling and administrative expenses -8.42%970.38K-12.41%3.72M2.67%839.81K-7.20%900.09K-27.36%919.37K-11.12%1.06M-12.37%4.25M-35.55%818K-15.68%969.95K17.70%1.27M
-General and administrative expense -8.42%970.38K-12.41%3.72M2.67%839.81K-7.20%900.09K-27.36%919.37K-11.12%1.06M-12.37%4.25M-35.55%818K-15.68%969.95K17.70%1.27M
Research and development costs -30.94%343.72K-78.59%1.73M-76.54%298.32K-76.94%374.2K-76.82%557.84K-82.03%497.71K-25.25%8.07M-56.42%1.27M-45.21%1.62M-25.01%2.41M
Operating profit 15.62%-1.31M55.77%-5.45M45.54%-1.14M50.84%-1.27M59.77%-1.48M60.69%-1.56M21.26%-12.32M50.10%-2.09M36.95%-2.59M14.29%-3.67M
Net non-operating interest income expense -43.68%22.77K123.64%150.9K-22.60%34.95K136.16%39.22K655.89%36.31K40.42K1,089.62%67.48K3,464.33%45.16K1,000.40%16.61K221.34%4.8K
Non-operating interest income -43.68%22.77K123.64%150.9K-22.60%34.95K136.16%39.22K655.89%36.31K--40.42K--67.48K--45.16K1,000.40%16.61K221.34%4.8K
Other net income (expense)
Income before tax 14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M37.33%-2.58M14.38%-3.67M
Income tax 0000000000
Net income 14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M37.33%-2.58M14.38%-3.67M
Net income continuous Operations 14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M37.33%-2.58M14.38%-3.67M
Minority interest income
Net income attributable to the parent company 14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M37.33%-2.58M14.38%-3.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M37.33%-2.58M14.38%-3.67M
Basic earnings per share 12.50%-0.0774.77%-0.2845.45%-0.0678.57%-0.0681.82%-0.0883.33%-0.0842.19%-1.1179.63%-0.1142.86%-0.2813.73%-0.44
Diluted earnings per share 12.50%-0.0774.77%-0.2845.45%-0.0678.57%-0.0681.82%-0.0883.33%-0.0842.19%-1.1179.63%-0.1142.86%-0.2813.73%-0.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg